ClinicalTrials.Veeva

Menu
S

Southwest Rheumatology Research, LLC | Mesquite, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Guselkumab
KPL-404
Secukinumab
Imvotamab
Baricitinib
Certolizumab
Afimetoran

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 12 total trials

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

The purpose of this study is to determine the safety and tolerability of imvotamab in patients with moderate to severe rheumatoid arthritis who have...

Enrolling
Arthritis
Arthritis, Rheumatoid
Drug: Imvotamab
Drug: Placebo

The purpose of this study is to evaluate the effectiveness, safety and tolerability of Afimetoran in participants with active Systemic Lupus Erythema...

Enrolling
Systemic Lupus Erythematosus
Other: Placebo
Drug: Afimetoran

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) axial disease by...

Enrolling
Arthritis, Psoriatic
Drug: Placebo
Drug: Guselkumab

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) by assessing the...

Enrolling
Arthritis, Psoriatic
Drug: Placebo
Drug: Guselkumab

The purpose of this study is to evaluate the efficacy of nipocalimab versus placebo in participants with active systemic lupus erythematosus (SLE).

Active, not recruiting
Systemic Lupus Erythematosus
Other: Placebo
Drug: Standard-of-care treatment

The purpose of this study is to evaluate the efficacy of combination therapy with nipocalimab and certolizumab compared to certolizumab monotherapy.

Active, not recruiting
Arthritis, Rheumatoid
Drug: Placebo
Drug: Nipocalimab

This study will evaluate the safety, tolerability, and effects of stimulating the splenic neurovascular bundle (NVB) with the Galvani System, which c...

Enrolling
Rheumatoid Arthritis
Drug: Baricitinib
Device: Active Stimulation

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) and inadequate re...

Enrolling
Arthritis, Psoriatic
Drug: Placebo
Drug: Guselkumab

The purpose of this study is to demonstrate the efficacy and safety of secukinumab 300 milligram (mg) and 150 mg administered subcutaneously (s.c.) f...

Enrolling
Polymyalgia Rheumatica
Drug: Secukinumab 150 mg
Other: Placebo to secukinumab
Locations recently updated

The purpose of this study is to assess long term safety in participants who have completed a Novartis trial with secukinumab, have been judged by the...

Enrolling
Autoimmunity, Inflammation
Biological: Secukinumab s.c. injection

Trial sponsors

Janssen (J&J Innovative Medicine) logo
Novartis logo
Amgen logo
Bristol-Myers Squibb (BMS) logo
G
I
K

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems